Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | saliva | DOI[10.1007/s11306-012-0464-y] | ||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | cerebrospinal fluid |
PMID[6656991] |
||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | cytoplasm |
PMID[15882454] |
||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | blood |
PMID[13654353] |
||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | urine |
PMID[22932811] |
||
NPO20338 | Mus musculus | Species | Muridae | Eukaryota |
PMID[19425150] |
|||
NPO4011 | Chlamydomonas reinhardtii | Species | Chlamydomonadaceae | Eukaryota |
PMID[25515814] |
|||
NPO730 | Escherichia coli | Species | Enterobacteriaceae | Bacteria |
PMID[21988831] |
|||
NPO27451 | Ophiocordyceps sinensis | Species | Ophiocordycipitaceae | Eukaryota | TM-MC* | |||
NPO28626 | Isodon rubescens | Species | Lamiaceae | Eukaryota | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT609 | Individual Protein | Human immunodeficiency virus type 1 protease | Human immunodeficiency virus 1 | Kd | = | 1.13 | nM | 12459011 |
NPT609 | Individual Protein | Human immunodeficiency virus type 1 protease | Human immunodeficiency virus 1 | Ki | = | 0.23 | nM | 12459011 |
NPT3541 | Protein Family | Phosphatidylinositol 4-kinase, PI4K | Homo sapiens | Inhibition | = | 31.3 | % | 2165159 |
NPT2266 | Individual Protein | Fructose-1,6-bisphosphatase | Homo sapiens | IC50 | = | 800 | nM | 11140724 |
NPT4492 | Individual Protein | P2Y purinoceptor 1 | Meleagris gallopavo | EC50 | = | 3500 | nM | 11754592 |
NPT3825 | Individual Protein | Purinergic receptor P2Y1 | Homo sapiens | EC50 | = | 7200 | nM | 11754592 |
NPT3826 | Individual Protein | Purinergic receptor P2Y2 | Homo sapiens | EC50 | = | 3700 | nM | 11754592 |
NPT4492 | Individual Protein | P2Y purinoceptor 1 | Meleagris gallopavo | EC50 | = | 2800 | nM | 11754592 |
NPT3825 | Individual Protein | Purinergic receptor P2Y1 | Homo sapiens | EC50 | = | 1500 | nM | 11754592 |
NPT3826 | Individual Protein | Purinergic receptor P2Y2 | Homo sapiens | EC50 | = | 85 | nM | 11754592 |
NPT3829 | Individual Protein | Purinergic receptor P2Y11 | Homo sapiens | EC50 | = | 17250 | nM | 11754592 |
NPT2 | Others | Unspecified | Activity | = | 100 | % | 11985476 | |
NPT4219 | Individual Protein | Choline acetylase | Homo sapiens | IC50 | = | 1.80E+12 | nM | 7310833 |
NPT334 | Organism | Vaccinia virus | Vaccinia virus | MIC50 | = | 2 | ug/ml | 4045916 |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | MIC50 | = | 7 | ug/ml | 4045916 |
NPT1141 | Organism | Human herpesvirus 2 | Human herpesvirus 2 | MIC50 | = | 7 | ug/ml | 4045916 |
NPT195 | Organism | Vesicular stomatitis virus | Vesicular stomatitis virus | MIC50 | = | 2 | ug/ml | 4045916 |
NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | MIC50 | = | 20 | ug/ml | 4045916 |
NPT2602 | Organism | Mammalian orthoreovirus 1 | Mammalian orthoreovirus 1 | MIC50 | >= | 10 | ug/ml | 4045916 |
NPT4758 | Organism | Human parainfluenza virus 1 | Human parainfluenza virus 1 | MIC50 | = | 2 | ug/ml | 4045916 |
NPT335 | Organism | Human coxsackievirus B4 | Human coxsackievirus B4 | MIC50 | >= | 10 | ug/ml | 4045916 |
NPT338 | Organism | Sindbis virus | Sindbis virus | MIC50 | > | 10 | ug/ml | 4045916 |
NPT856 | Organism | Semliki forest virus | Semliki forest virus | MIC50 | >= | 10 | ug/ml | 4045916 |
NPT1049 | Organism | Measles virus | Measles virus | MIC50 | >= | 10 | ug/ml | 4045916 |
NPT189 | Cell Line | Vero | Chlorocebus aethiops | MIC50 | = | 10 | ug/ml | 4045916 |
NPT195 | Organism | Vesicular stomatitis virus | Vesicular stomatitis virus | MIC50 | = | 7 | ug/ml | 4045916 |
NPT335 | Organism | Human coxsackievirus B4 | Human coxsackievirus B4 | MIC50 | > | 10 | ug/ml | 4045916 |
NPT1106 | Organism | Human poliovirus 1 | Human poliovirus 1 | MIC50 | > | 10 | ug/ml | 4045916 |
NPT165 | Cell Line | HeLa | Homo sapiens | MIC50 | = | 20 | ug/ml | 4045916 |
NPT137 | Cell Line | L1210 | Mus musculus | MIC50 | = | 3.1 | ug/ml | 4045916 |
NPT334 | Organism | Vaccinia virus | Vaccinia virus | MIC50 | > | 400 | ug/ml | 4045916 |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | MIC50 | = | 200 | ug/ml | 4045916 |
NPT1141 | Organism | Human herpesvirus 2 | Human herpesvirus 2 | MIC50 | >= | 400 | ug/ml | 4045916 |
NPT195 | Organism | Vesicular stomatitis virus | Vesicular stomatitis virus | MIC50 | > | 400 | ug/ml | 4045916 |
NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | MIC50 | > | 400 | ug/ml | 4045916 |
NPT2602 | Organism | Mammalian orthoreovirus 1 | Mammalian orthoreovirus 1 | MIC50 | > | 200 | ug/ml | 4045916 |
NPT4758 | Organism | Human parainfluenza virus 1 | Human parainfluenza virus 1 | MIC50 | > | 200 | ug/ml | 4045916 |
NPT335 | Organism | Human coxsackievirus B4 | Human coxsackievirus B4 | MIC50 | > | 200 | ug/ml | 4045916 |
NPT338 | Organism | Sindbis virus | Sindbis virus | MIC50 | > | 200 | ug/ml | 4045916 |
NPT856 | Organism | Semliki forest virus | Semliki forest virus | MIC50 | > | 200 | ug/ml | 4045916 |
NPT1049 | Organism | Measles virus | Measles virus | MIC50 | > | 200 | ug/ml | 4045916 |
NPT189 | Cell Line | Vero | Chlorocebus aethiops | MIC50 | > | 400 | ug/ml | 4045916 |
NPT335 | Organism | Human coxsackievirus B4 | Human coxsackievirus B4 | MIC50 | > | 400 | ug/ml | 4045916 |
NPT1106 | Organism | Human poliovirus 1 | Human poliovirus 1 | MIC50 | > | 400 | ug/ml | 4045916 |
NPT165 | Cell Line | HeLa | Homo sapiens | MIC50 | > | 400 | ug/ml | 4045916 |
NPT137 | Cell Line | L1210 | Mus musculus | MIC50 | > | 100 | ug/ml | 4045916 |
NPT4759 | Individual Protein | Adenylate kinase 2 | Rattus norvegicus | Ki | = | 80000 | nM | 6292418 |
NPT4760 | Individual Protein | Adenylate kinase 1 | Rattus norvegicus | Ki | = | 580000 | nM | 6292418 |
NPT5046 | Individual Protein | Inosine-5'-monophosphate dehydrogenase | Escherichia coli K-12 | Ki | = | 450000 | nM | 6120232 |
NPT1347 | Protein Family | Alcohol dehydrogenase | Equus caballus | Ki | = | 38000 | nM | 7021832 |
NPT3582 | Individual Protein | Ketopantoate reductase | Escherichia coli K-12 | Kd | > | 5000000 | nM | 16884311 |
NPT3582 | Individual Protein | Ketopantoate reductase | Escherichia coli K-12 | Ki | = | 6300000 | nM | 16884311 |
NPT36 | Individual Protein | Tyrosine-protein kinase SRC | Homo sapiens | IC50 | = | 100 | nM | 1479375 |
NPT2 | Others | Unspecified | IC50 | = | 300 | nM | 1479375 | |
NPT2266 | Individual Protein | Fructose-1,6-bisphosphatase | Homo sapiens | IC50 | = | 1000 | nM | 19348494 |
NPT3967 | Individual Protein | Fructose-1,6-bisphosphatase | Sus scrofa | IC50 | = | 1300 | nM | 19419876 |
NPT2 | Others | Unspecified | Kd | = | 5400 | nM | 19678707 | |
NPT2 | Others | Unspecified | Kd | = | 21000 | nM | 19678707 | |
NPT2 | Others | Unspecified | Kd | = | 31000 | nM | 19678707 | |
NPT2 | Others | Unspecified | Ratio | = | 5 | 19678707 | ||
NPT2266 | Individual Protein | Fructose-1,6-bisphosphatase | Homo sapiens | IC50 | = | 440 | nM | 19969452 |
NPT2266 | Individual Protein | Fructose-1,6-bisphosphatase | Homo sapiens | IC50 | = | 140 | nM | 19969452 |
NPT3967 | Individual Protein | Fructose-1,6-bisphosphatase | Sus scrofa | IC50 | = | 1300 | nM | 20116906 |
NPT2266 | Individual Protein | Fructose-1,6-bisphosphatase | Homo sapiens | IC50 | = | 9800 | nM | 20116906 |
NPT2 | Others | Unspecified | AC50 | = | 56000 | nM | 20154666 | |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT2628 | Individual Protein | Luciferase | Photuris pennsylvanica | Potency | = | 1995.3 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | EC50 | = | 1400 | nM | 24900234 | |
NPT2 | Others | Unspecified | IC50 | = | 1000 | nM | 24900234 | |
NPT2 | Others | Unspecified | EC50 | = | 5900 | nM | 24900234 | |
NPT62 | Individual Protein | 6-phospho-1-fructokinase | Trypanosoma brucei | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 223.9 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 15101.4 | nM | PubChem BioAssay data set | |
NPT698 | Individual Protein | Regulator of G-protein signaling 4 | Homo sapiens | Potency | 1888.8 | nM | PubChem BioAssay data set | |
NPT644 | Individual Protein | L-lactate dehydrogenase A chain | Homo sapiens | Kd | = | 650000 | nM | 22417091 |
NPT644 | Individual Protein | L-lactate dehydrogenase A chain | Homo sapiens | IC50 | > | 500000 | nM | 22417091 |
NPT2 | Others | Unspecified | IC50 | = | 12300 | nM | 22960695 | |
NPT216 | Individual Protein | Adenosine A1 receptor | Homo sapiens | EC50 | = | 500 | nM | 22738238 |
NPT2 | Others | Unspecified | Potency | 29092.9 | nM | PubChem BioAssay data set | ||
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 91.52 | % | 23571415 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 90.72 | % | 23571415 |
NPT4506 | Individual Protein | Transient receptor potential cation channel subfamily M member 2 | Homo sapiens | IC50 | = | 70000 | nM | 24304219 |
NPT2266 | Individual Protein | Fructose-1,6-bisphosphatase | Homo sapiens | IC50 | = | 3200 | nM | 24530031 |
NPT2 | Others | Unspecified | Potency | 10590.1 | nM | PubChem BioAssay data set | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 11883.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 10682.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 11882.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 84.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 13332.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 11883.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 21313.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1883.4 | nM | PubChem BioAssay data set | ||
NPT2266 | Individual Protein | Fructose-1,6-bisphosphatase | Homo sapiens | IC50 | = | 1000 | nM | 10.1039/C0MD00269K |
NPT2 | Others | Unspecified | FC | = | 0.12 | 671448 | ||
NPT2 | Others | Unspecified | Activity | = | 100 | % | 966249 | |
NPT2 | Others | Unspecified | IC50 | = | 1300 | nM | 24946215 | |
NPT5047 | Individual Protein | 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | Homo sapiens | Ki | = | 19200 | nM | 25108359 |
NPT5048 | Individual Protein | 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | Rattus norvegicus | Ki | = | 40000 | nM | 25108359 |
NPT2266 | Individual Protein | Fructose-1,6-bisphosphatase | Homo sapiens | IC50 | = | 3200 | nM | 25461330 |
NPT2 | Others | Unspecified | Potency | 18995.9 | nM | PubChem BioAssay data set | ||
NPT74 | Individual Protein | Proto-oncogene c-JUN | Homo sapiens | Potency | 23914.5 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 7562.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 12589.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 23914.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 7497.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 298.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 10000 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC185991 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC211025 |
1.0 | High Similarity | NPC85689 |
0.9928 | High Similarity | NPC321814 |
0.9857 | High Similarity | NPC302778 |
0.9857 | High Similarity | NPC130586 |
0.9857 | High Similarity | NPC164952 |
0.9857 | High Similarity | NPC212551 |
0.9787 | High Similarity | NPC174802 |
0.9783 | High Similarity | NPC121222 |
0.9718 | High Similarity | NPC224076 |
0.965 | High Similarity | NPC316618 |
0.965 | High Similarity | NPC226245 |
0.9574 | High Similarity | NPC161224 |
0.9565 | High Similarity | NPC156461 |
0.9565 | High Similarity | NPC21448 |
0.9565 | High Similarity | NPC107374 |
0.9496 | High Similarity | NPC189068 |
0.9496 | High Similarity | NPC164665 |
0.9429 | High Similarity | NPC309832 |
0.9429 | High Similarity | NPC219313 |
0.9429 | High Similarity | NPC269827 |
0.942 | High Similarity | NPC229974 |
0.9324 | High Similarity | NPC323091 |
0.9275 | High Similarity | NPC209525 |
0.9275 | High Similarity | NPC161659 |
0.9143 | High Similarity | NPC314152 |
0.9137 | High Similarity | NPC317821 |
0.9103 | High Similarity | NPC472816 |
0.8947 | High Similarity | NPC261595 |
0.8889 | High Similarity | NPC324033 |
0.8889 | High Similarity | NPC321458 |
0.8859 | High Similarity | NPC239737 |
0.8846 | High Similarity | NPC326529 |
0.8844 | High Similarity | NPC207633 |
0.8794 | High Similarity | NPC129756 |
0.879 | High Similarity | NPC324198 |
0.879 | High Similarity | NPC189261 |
0.879 | High Similarity | NPC319100 |
0.871 | High Similarity | NPC326082 |
0.8707 | High Similarity | NPC150853 |
0.8639 | High Similarity | NPC136349 |
0.8609 | High Similarity | NPC313754 |
0.8609 | High Similarity | NPC311197 |
0.8609 | High Similarity | NPC54320 |
0.8543 | High Similarity | NPC52238 |
0.8467 | Intermediate Similarity | NPC328479 |
0.8462 | Intermediate Similarity | NPC30326 |
0.8462 | Intermediate Similarity | NPC33996 |
0.8451 | Intermediate Similarity | NPC320818 |
0.8367 | Intermediate Similarity | NPC274384 |
0.8367 | Intermediate Similarity | NPC89147 |
0.8299 | Intermediate Similarity | NPC211820 |
0.8299 | Intermediate Similarity | NPC251233 |
0.8288 | Intermediate Similarity | NPC186619 |
0.8243 | Intermediate Similarity | NPC177169 |
0.8194 | Intermediate Similarity | NPC195140 |
0.8188 | Intermediate Similarity | NPC232408 |
0.8188 | Intermediate Similarity | NPC64705 |
0.8176 | Intermediate Similarity | NPC318590 |
0.8129 | Intermediate Similarity | NPC93365 |
0.8121 | Intermediate Similarity | NPC317746 |
0.8092 | Intermediate Similarity | NPC326694 |
0.805 | Intermediate Similarity | NPC324484 |
0.8012 | Intermediate Similarity | NPC290959 |
0.8 | Intermediate Similarity | NPC325906 |
0.7945 | Intermediate Similarity | NPC61198 |
0.7877 | Intermediate Similarity | NPC262926 |
0.7756 | Intermediate Similarity | NPC321052 |
0.7711 | Intermediate Similarity | NPC313897 |
0.7702 | Intermediate Similarity | NPC14590 |
0.7687 | Intermediate Similarity | NPC319221 |
0.7619 | Intermediate Similarity | NPC324009 |
0.75 | Intermediate Similarity | NPC24589 |
0.7471 | Intermediate Similarity | NPC282458 |
0.7471 | Intermediate Similarity | NPC78941 |
0.7403 | Intermediate Similarity | NPC315642 |
0.7403 | Intermediate Similarity | NPC74306 |
0.7273 | Intermediate Similarity | NPC313514 |
0.7246 | Intermediate Similarity | NPC33382 |
0.7202 | Intermediate Similarity | NPC168702 |
0.7202 | Intermediate Similarity | NPC125659 |
0.7118 | Intermediate Similarity | NPC222174 |
0.7006 | Intermediate Similarity | NPC321393 |
0.6989 | Remote Similarity | NPC276373 |
0.6952 | Remote Similarity | NPC5802 |
0.6918 | Remote Similarity | NPC327579 |
0.6915 | Remote Similarity | NPC157821 |
0.6866 | Remote Similarity | NPC107160 |
0.6765 | Remote Similarity | NPC21461 |
0.6714 | Remote Similarity | NPC476564 |
0.671 | Remote Similarity | NPC57279 |
0.6688 | Remote Similarity | NPC246193 |
0.6688 | Remote Similarity | NPC104011 |
0.6667 | Remote Similarity | NPC158055 |
0.6619 | Remote Similarity | NPC174114 |
0.6619 | Remote Similarity | NPC87981 |
0.66 | Remote Similarity | NPC250178 |
0.6579 | Remote Similarity | NPC248007 |
0.6483 | Remote Similarity | NPC312187 |
0.6483 | Remote Similarity | NPC4837 |
0.6392 | Remote Similarity | NPC103388 |
0.6382 | Remote Similarity | NPC139776 |
0.6369 | Remote Similarity | NPC287876 |
0.6306 | Remote Similarity | NPC14330 |
0.6286 | Remote Similarity | NPC160666 |
0.625 | Remote Similarity | NPC18335 |
0.6221 | Remote Similarity | NPC472834 |
0.609 | Remote Similarity | NPC109322 |
0.6013 | Remote Similarity | NPC68938 |
0.5946 | Remote Similarity | NPC164845 |
0.5924 | Remote Similarity | NPC5707 |
0.5921 | Remote Similarity | NPC313547 |
0.5917 | Remote Similarity | NPC217656 |
0.5882 | Remote Similarity | NPC89139 |
0.5868 | Remote Similarity | NPC296437 |
0.5849 | Remote Similarity | NPC180493 |
0.5833 | Remote Similarity | NPC470266 |
0.5806 | Remote Similarity | NPC189314 |
0.5782 | Remote Similarity | NPC476561 |
0.578 | Remote Similarity | NPC244700 |
0.5765 | Remote Similarity | NPC476528 |
0.5765 | Remote Similarity | NPC476433 |
0.5731 | Remote Similarity | NPC474986 |
0.5731 | Remote Similarity | NPC476520 |
0.5731 | Remote Similarity | NPC476013 |
0.5731 | Remote Similarity | NPC476522 |
0.573 | Remote Similarity | NPC472833 |
0.5729 | Remote Similarity | NPC265111 |
0.5723 | Remote Similarity | NPC476408 |
0.5698 | Remote Similarity | NPC476521 |
0.5684 | Remote Similarity | NPC473585 |
0.5667 | Remote Similarity | NPC119133 |
0.5635 | Remote Similarity | NPC472832 |
0.5635 | Remote Similarity | NPC18308 |
0.56 | Remote Similarity | NPC476099 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC185991 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD283 | Approved |
0.9857 | High Similarity | NPD242 | Approved |
0.9857 | High Similarity | NPD338 | Approved |
0.9787 | High Similarity | NPD339 | Approved |
0.9718 | High Similarity | NPD169 | Phase 2 |
0.9565 | High Similarity | NPD249 | Approved |
0.9565 | High Similarity | NPD250 | Approved |
0.9429 | High Similarity | NPD186 | Discovery |
0.9429 | High Similarity | NPD195 | Approved |
0.9143 | High Similarity | NPD185 | Approved |
0.9041 | High Similarity | NPD3107 | Discontinued |
0.9041 | High Similarity | NPD1369 | Phase 2 |
0.9041 | High Similarity | NPD1750 | Clinical (unspecified phase) |
0.9014 | High Similarity | NPD166 | Approved |
0.9 | High Similarity | NPD193 | Suspended |
0.8947 | High Similarity | NPD247 | Clinical (unspecified phase) |
0.8859 | High Similarity | NPD2624 | Phase 2 |
0.8859 | High Similarity | NPD2646 | Discontinued |
0.8859 | High Similarity | NPD1732 | Phase 3 |
0.8824 | High Similarity | NPD7988 | Suspended |
0.879 | High Similarity | NPD4171 | Clinical (unspecified phase) |
0.8734 | High Similarity | NPD1412 | Clinical (unspecified phase) |
0.8639 | High Similarity | NPD548 | Clinical (unspecified phase) |
0.8627 | High Similarity | NPD3083 | Approved |
0.8625 | High Similarity | NPD4716 | Approved |
0.8609 | High Similarity | NPD218 | Approved |
0.8609 | High Similarity | NPD220 | Clinical (unspecified phase) |
0.8609 | High Similarity | NPD219 | Phase 3 |
0.8609 | High Similarity | NPD216 | Approved |
0.8609 | High Similarity | NPD217 | Approved |
0.8571 | High Similarity | NPD4744 | Clinical (unspecified phase) |
0.8411 | Intermediate Similarity | NPD214 | Approved |
0.8411 | Intermediate Similarity | NPD213 | Clinical (unspecified phase) |
0.8408 | Intermediate Similarity | NPD2647 | Phase 3 |
0.8364 | Intermediate Similarity | NPD6417 | Clinical (unspecified phase) |
0.8263 | Intermediate Similarity | NPD2631 | Clinical (unspecified phase) |
0.8263 | Intermediate Similarity | NPD2630 | Approved |
0.8263 | Intermediate Similarity | NPD2632 | Approved |
0.8227 | Intermediate Similarity | NPD248 | Discontinued |
0.8156 | Intermediate Similarity | NPD9633 | Phase 3 |
0.8148 | Intermediate Similarity | NPD5666 | Phase 2 |
0.8129 | Intermediate Similarity | NPD546 | Clinical (unspecified phase) |
0.8121 | Intermediate Similarity | NPD7158 | Phase 1 |
0.8099 | Intermediate Similarity | NPD9632 | Phase 3 |
0.8071 | Intermediate Similarity | NPD9408 | Phase 3 |
0.8 | Intermediate Similarity | NPD1777 | Approved |
0.8 | Intermediate Similarity | NPD1776 | Approved |
0.7958 | Intermediate Similarity | NPD870 | Clinical (unspecified phase) |
0.7945 | Intermediate Similarity | NPD252 | Clinical (unspecified phase) |
0.7857 | Intermediate Similarity | NPD3085 | Phase 1 |
0.7848 | Intermediate Similarity | NPD4074 | Clinical (unspecified phase) |
0.7811 | Intermediate Similarity | NPD1692 | Approved |
0.7806 | Intermediate Similarity | NPD3086 | Phase 3 |
0.775 | Intermediate Similarity | NPD516 | Clinical (unspecified phase) |
0.7733 | Intermediate Similarity | NPD549 | Approved |
0.7719 | Intermediate Similarity | NPD5682 | Phase 3 |
0.7719 | Intermediate Similarity | NPD5683 | Clinical (unspecified phase) |
0.7719 | Intermediate Similarity | NPD5684 | Clinical (unspecified phase) |
0.7635 | Intermediate Similarity | NPD194 | Clinical (unspecified phase) |
0.7616 | Intermediate Similarity | NPD3695 | Approved |
0.7616 | Intermediate Similarity | NPD3696 | Approved |
0.7586 | Intermediate Similarity | NPD4054 | Clinical (unspecified phase) |
0.7532 | Intermediate Similarity | NPD536 | Clinical (unspecified phase) |
0.7403 | Intermediate Similarity | NPD582 | Approved |
0.7308 | Intermediate Similarity | NPD171 | Discontinued |
0.7296 | Intermediate Similarity | NPD3708 | Phase 2 |
0.7273 | Intermediate Similarity | NPD7138 | Phase 2 |
0.725 | Intermediate Similarity | NPD353 | Discontinued |
0.7244 | Intermediate Similarity | NPD4240 | Approved |
0.7216 | Intermediate Similarity | NPD1063 | Phase 2 |
0.7099 | Intermediate Similarity | NPD231 | Clinical (unspecified phase) |
0.7059 | Intermediate Similarity | NPD2965 | Clinical (unspecified phase) |
0.7021 | Intermediate Similarity | NPD2876 | Phase 3 |
0.7021 | Intermediate Similarity | NPD2877 | Clinical (unspecified phase) |
0.6994 | Remote Similarity | NPD9605 | Phase 3 |
0.6966 | Remote Similarity | NPD9606 | Approved |
0.6947 | Remote Similarity | NPD2824 | Phase 2 |
0.6923 | Remote Similarity | NPD5080 | Phase 2 |
0.6918 | Remote Similarity | NPD9607 | Approved |
0.6875 | Remote Similarity | NPD1046 | Clinical (unspecified phase) |
0.6872 | Remote Similarity | NPD5079 | Phase 2 |
0.6804 | Remote Similarity | NPD2902 | Phase 2 |
0.6804 | Remote Similarity | NPD2903 | Clinical (unspecified phase) |
0.6774 | Remote Similarity | NPD209 | Clinical (unspecified phase) |
0.6757 | Remote Similarity | NPD9409 | Discontinued |
0.671 | Remote Similarity | NPD545 | Clinical (unspecified phase) |
0.6701 | Remote Similarity | NPD4495 | Phase 1 |
0.6667 | Remote Similarity | NPD6840 | Approved |
0.6644 | Remote Similarity | NPD9374 | Approved |
0.6628 | Remote Similarity | NPD527 | Clinical (unspecified phase) |
0.6626 | Remote Similarity | NPD1730 | Discontinued |
0.6621 | Remote Similarity | NPD9373 | Approved |
0.6603 | Remote Similarity | NPD547 | Clinical (unspecified phase) |
0.6579 | Remote Similarity | NPD9084 | Phase 2 |
0.6577 | Remote Similarity | NPD307 | Approved |
0.6538 | Remote Similarity | NPD282 | Approved |
0.6519 | Remote Similarity | NPD1119 | Phase 2 |
0.6446 | Remote Similarity | NPD775 | Approved |
0.6398 | Remote Similarity | NPD2152 | Clinical (unspecified phase) |
0.638 | Remote Similarity | NPD1430 | Approved |
0.638 | Remote Similarity | NPD2253 | Discontinued |
0.638 | Remote Similarity | NPD1431 | Approved |
0.6369 | Remote Similarity | NPD8829 | Clinical (unspecified phase) |
0.6352 | Remote Similarity | NPD9083 | Clinical (unspecified phase) |
0.6352 | Remote Similarity | NPD1058 | Discontinued |
0.631 | Remote Similarity | NPD207 | Discontinued |
0.6309 | Remote Similarity | NPD9584 | Phase 2 |
0.6289 | Remote Similarity | NPD4458 | Phase 2 |
0.6289 | Remote Similarity | NPD4459 | Clinical (unspecified phase) |
0.6287 | Remote Similarity | NPD7531 | Clinical (unspecified phase) |
0.625 | Remote Similarity | NPD8836 | Approved |
0.6242 | Remote Similarity | NPD1128 | Approved |
0.6242 | Remote Similarity | NPD1127 | Approved |
0.6218 | Remote Similarity | NPD281 | Approved |
0.6196 | Remote Similarity | NPD799 | Phase 1 |
0.6196 | Remote Similarity | NPD1808 | Phase 1 |
0.6135 | Remote Similarity | NPD6112 | Approved |
0.6122 | Remote Similarity | NPD9416 | Phase 3 |
0.6122 | Remote Similarity | NPD9417 | Phase 3 |
0.6121 | Remote Similarity | NPD1118 | Discontinued |
0.6107 | Remote Similarity | NPD9375 | Discontinued |
0.609 | Remote Similarity | NPD798 | Discontinued |
0.6074 | Remote Similarity | NPD535 | Approved |
0.6074 | Remote Similarity | NPD1120 | Approved |
0.6074 | Remote Similarity | NPD1121 | Approved |
0.6058 | Remote Similarity | NPD6381 | Phase 2 |
0.6027 | Remote Similarity | NPD9626 | Clinical (unspecified phase) |
0.6012 | Remote Similarity | NPD9484 | Clinical (unspecified phase) |
0.6011 | Remote Similarity | NPD2593 | Clinical (unspecified phase) |
0.601 | Remote Similarity | NPD5486 | Discontinued |
0.598 | Remote Similarity | NPD4713 | Clinical (unspecified phase) |
0.598 | Remote Similarity | NPD34 | Approved |
0.598 | Remote Similarity | NPD4715 | Clinical (unspecified phase) |
0.598 | Remote Similarity | NPD4714 | Approved |
0.5975 | Remote Similarity | NPD515 | Phase 1 |
0.5972 | Remote Similarity | NPD7502 | Clinical (unspecified phase) |
0.5952 | Remote Similarity | NPD1117 | Clinical (unspecified phase) |
0.5946 | Remote Similarity | NPD1816 | Clinical (unspecified phase) |
0.5934 | Remote Similarity | NPD9582 | Phase 3 |
0.5924 | Remote Similarity | NPD8830 | Phase 3 |
0.592 | Remote Similarity | NPD5458 | Discontinued |
0.5919 | Remote Similarity | NPD8250 | Phase 2 |
0.5918 | Remote Similarity | NPD691 | Discontinued |
0.5891 | Remote Similarity | NPD2452 | Phase 2 |
0.5891 | Remote Similarity | NPD2450 | Phase 2 |
0.5891 | Remote Similarity | NPD2453 | Phase 2 |
0.5891 | Remote Similarity | NPD2451 | Phase 2 |
0.5882 | Remote Similarity | NPD9406 | Approved |
0.5862 | Remote Similarity | NPD7842 | Phase 2 |
0.5849 | Remote Similarity | NPD9544 | Approved |
0.5849 | Remote Similarity | NPD78 | Approved |
0.5813 | Remote Similarity | NPD796 | Phase 2 |
0.5806 | Remote Similarity | NPD8833 | Approved |
0.5806 | Remote Similarity | NPD8831 | Approved |
0.5802 | Remote Similarity | NPD6036 | Suspended |
0.5779 | Remote Similarity | NPD757 | Phase 3 |
0.5769 | Remote Similarity | NPD9360 | Approved |
0.5735 | Remote Similarity | NPD534 | Phase 2 |
0.5735 | Remote Similarity | NPD537 | Phase 2 |
0.5734 | Remote Similarity | NPD5627 | Approved |
0.5705 | Remote Similarity | NPD1368 | Approved |
0.57 | Remote Similarity | NPD5665 | Clinical (unspecified phase) |
0.5679 | Remote Similarity | NPD1775 | Approved |
0.5679 | Remote Similarity | NPD1085 | Approved |
0.5676 | Remote Similarity | NPD3849 | Clinical (unspecified phase) |
0.5669 | Remote Similarity | NPD237 | Clinical (unspecified phase) |
0.5667 | Remote Similarity | NPD9291 | Approved |
0.566 | Remote Similarity | NPD2221 | Clinical (unspecified phase) |
0.566 | Remote Similarity | NPD4555 | Clinical (unspecified phase) |
0.5659 | Remote Similarity | NPD5768 | Phase 2 |
0.5642 | Remote Similarity | NPD1017 | Clinical (unspecified phase) |
0.564 | Remote Similarity | NPD9704 | Approved |
0.5619 | Remote Similarity | NPD3913 | Clinical (unspecified phase) |
0.5614 | Remote Similarity | NPD6351 | Discovery |
Molecular Weight:   | 347.06 |
ALogP:   | -2.2149 |
MLogP:   | 1.13 |
XLogP:   | -3.467 |
# Rotatable Bonds:   | 9 |
Polar Surface Area:   | 195.88 |
# H-Bond Aceptor:   | 12 |
# H-Bond Donor:   | 5 |
# Rings:   | 3 |
# Heavy Atoms:   | 23 |